Renaissance Technologies’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-1,226
| Closed | -$6K | – | 4705 |
|
2022
Q1 | $6K | Sell |
1,226
-8,133
| -87% | -$39.8K | ﹤0.01% | 4032 |
|
2021
Q4 | $53K | Buy |
+9,359
| New | +$53K | ﹤0.01% | 3781 |
|
2021
Q3 | – | Sell |
-100,526
| Closed | -$1.7M | – | 4003 |
|
2021
Q2 | $1.7M | Buy |
+100,526
| New | +$1.7M | ﹤0.01% | 2367 |
|
2020
Q3 | – | Sell |
-18,574
| Closed | -$788K | – | 3806 |
|
2020
Q2 | $788K | Buy |
18,574
+17,627
| +1,861% | +$748K | ﹤0.01% | 2667 |
|
2020
Q1 | $76K | Sell |
947
-2,210
| -70% | -$177K | ﹤0.01% | 3273 |
|
2019
Q4 | $292K | Buy |
3,157
+2,124
| +206% | +$196K | ﹤0.01% | 3079 |
|
2019
Q3 | $78K | Buy |
+1,033
| New | +$78K | ﹤0.01% | 3291 |
|
2017
Q3 | – | Sell |
-623
| Closed | -$30K | – | 3439 |
|
2017
Q2 | $30K | Buy |
623
+504
| +424% | +$24.3K | ﹤0.01% | 3148 |
|
2017
Q1 | $17K | Buy |
+119
| New | +$17K | ﹤0.01% | 3180 |
|